89 results
PRE 14A
ATHA
Athira Pharma Inc
28 Mar 24
Preliminary proxy
8:47am
in Control and Severance Agreements
Equity Incentive Plans
Clawback Policy
Executive Incentive Compensation Plan
SECURITY OWNERSHIP OF CERTAIN … in Control. In the event of our change in control, as defined in our 2020 Equity Incentive Plan, each non-employee director’s then outstanding equity awards
S-8
ATHA
Athira Pharma Inc
22 Feb 24
Registration of securities for employees
4:34pm
to the 2020 Equity Incentive Plan
Other (5)
Equity
Common Stock, $0.0001 par value per share, reserved for issuance pursuant to the 2024 Inducement Equity … Incentive Plan
Other(5)
Total Fee Offsets
Net Fee Due
(1)Represents shares of common stock, par value $0.0001 per share (“Common Stock”) of Athira
S-8
EX-5.1
ATHA
Athira Pharma Inc
22 Feb 24
Registration of securities for employees
4:34pm
) 1,908,630 shares of common stock to be issued under the 2020 Equity Incentive Plan (the “2020 Plan”), (ii) 381,726 shares of common stock to be issued … Incentive Plan (the “2024 Inducement Plan”, and together with the 2020 Plan and 2020 ESPP, the “Plans”). As your legal counsel, we have reviewed
S-8
kzyka5
22 Feb 24
Registration of securities for employees
4:34pm
S-8
EX-23.1
n3egcojqy632p tip
22 Feb 24
Registration of securities for employees
4:34pm
8-K
EX-10.1
4spbzpwm0t2 38lu6
22 Feb 24
Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
4:10pm
8-K
lldtp3i
22 Feb 24
Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
4:10pm
8-K
EX-10.1
kps2rq6wxs
8 Jan 24
Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update
7:11am
8-K
epyrr4pgjrqw1
8 Jan 24
Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update
7:11am
8-K
3btjsk 5ri2
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
8-K
EX-10.1
5p838in8f3
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
8-K
EX-10.3
7uck0utuc0gn85vdq8
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am